Abstract
The aim of Chinese pharmaceutical industry restructuring and upgrading is to achieve the transformation from incremental expansion to the stock adjustment road. As the mail strength of industrial restructuring, pharmaceutical companies of state-owned and state-holding are the main object of pharmaceuticals industry mixed ownership reforms. Basing on the analyzing of mixed ownership reforming process and industry restructuring, the paper discussed the impacting factors of Chinese pharmaceutical restructuring with the empirical analysis of Panel Data model. Result display that the state-owned companies perform the more quantity, extensive mode of production, which need the stock adjustment model. Restructuring road include the incremental and stock adjusting, micro-stock adjusting, social capital participating and state-owned capital exchange building.
Highlights
In the third plenary session of 18th the Communist Party of China (CPC) Congress, it has been definitely put forward to reforming the operation and management modes, getting rid of the monopoly and changing the past assets control to the capital control of state-owned enterprises, which would be benefit to strengthen the National Capital Control in future
Based on the policy target forwarded in the fifth plenary session of 18th the CPC Congress, the economic structure should adjust from incremental expansions to Stock Adjustment and the state-owned enterprises would take an important role in this process
Under way to reform the ownership conditions, Pharmaceutical industry restructuring are different in terms of obtaining resources and different enterprise profit will be occurred, these resources are mainly performed in human resources, enterprise scale, fixed assets, provision of new products aspects
Summary
In the third plenary session of 18th the Communist Party of China (CPC) Congress, it has been definitely put forward to reforming the operation and management modes, getting rid of the monopoly and changing the past assets control to the capital control of state-owned enterprises, which would be benefit to strengthen the National Capital Control in future. Adopting the reform mode of the mixed ownership, it will stimulate the vitality of state-owned capital and promote social capital investment in a wider field operation. These would break the monopoly of state-owned enterprises gradually. The reformation of ownership for state-owned pharmaceuticals has been conducted step by step after the third plenary session of 12th the CPC Congress, and deeply reformation in the mixed ownership has been conducted in the third plenary session of 18th the CPC Congress
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
